Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,730 across all filing types
Latest filing 2024-07-17 Major Shareholding Noti…
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
113年07月內部人持股轉讓(事前)
Major Shareholding Notification Classification · 100% confidence The document is a notification of a share transfer by a major shareholder, detailing the transfer method, number of shares, and parties involved. It includes specific data about shareholding changes and transfer periods. This matches the definition of a Major Shareholding Notification, which reports changes in significant share ownership levels. The document is short and focused solely on shareholding changes, not a full report or announcement of a meeting or financial results.
2024-07-17 Chinese
113年6月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (美時) providing information about fund lending balances and endorsement guarantees for the current and previous months, including limits and cumulative amounts. The content is a regulatory disclosure of financial data related to intercompany and regional guarantees and loans. The document is short (614 characters) and contains specific financial data but does not present a full financial report or detailed analysis. It is a typical regulatory announcement of financial status related to guarantees and loans rather than a comprehensive report like an Annual Report or Interim Report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2024-07-10 Chinese
113年6月營業收入
Fund Information / Factsheet Classification · 85% confidence The document is a summary report of monthly and cumulative operating revenue figures for a company named 美時, presented in a tabular format with explanations about accounting standards and reporting practices. It contains no detailed financial statements, management discussion, or comprehensive analysis. The length is short (776 characters), and it appears to be a brief financial data summary rather than a full report or announcement. It does not announce a report publication or voting results, nor is it a regulatory filing or certification. Given the concise nature and focus on key financial figures, this fits best as a Fund Information / Factsheet (FS), which is a brief summary of key company facts and financials.
2024-07-10 Chinese
113年06月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, general managers, deputy general managers, and major shareholders. It shows the number of shares held, changes in holdings, and related information. This type of document is a report of personal share transactions or holdings by company directors and executives, which matches the definition of Director's Dealing filings. There is no indication that this is an announcement of a report or a certification. The document length is substantial and contains actual data on insider shareholdings, not just a summary or announcement. Therefore, the appropriate classification is Director's Dealing (DIRS).
2024-07-03 Chinese
113年06月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, independent directors, general managers, and major shareholders. It lists the number of shares held, pledged shares, and related percentages. The content is focused on insider shareholdings and their changes or status. There is no indication of financial statements, earnings data, meeting materials, or legal proceedings. The document is a notification of insider shareholdings, which aligns with the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives. The document length is 3803 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full financial report. Therefore, the most appropriate classification is DIRS.
2024-07-03 Chinese
本公司受邀參加國寬量國際主辦之「Taiwan Healthcare Corporate Day」
Investor Presentation Classification · 90% confidence The document is a brief announcement about the company (1795 美時) participating in a corporate day event organized by Taiwan Healthcare Corporate Day. It mentions the date and time of a scheduled investor presentation and states that detailed financial and business information can be found on the public information observatory website. The document does not contain actual financial data or detailed report content but rather announces the occurrence of an investor presentation event. The length is short (697 characters), and it serves as a notification of an upcoming or recent investor presentation rather than the presentation itself or a detailed report. Therefore, it fits best under the category of Investor Presentation (IP).
2024-06-24 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.